1-4 of 4
Janette Sutton
Close
Sort by
Journal Articles

Preclinical Evaluation of ALLO-605, an Allogeneic BCMA Turbocar T TM Cell Therapy for the Treatment of Multiple Myeloma

Cesar Sommer, PhD, Regina Lin, PhD, Janette Sutton, Trevor Bentley, Duy Nguyen, Hayung Yoon, Melinda Au, Diego Vargas-Inchaustegui, PhD, Hsin-Yuan Cheng, PhD, Tom Van Blarcom, Siler Panowski, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-141477
Published: 2020
Journal Articles

Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia

Cesar Sommer, PhD, Hsin-Yuan Cheng, PhD, Yik Andy Yeung, PhD, Duy Nguyen, Janette Sutton, Zea Melton, Julien Valton, PhD, Kris Poulsen, Ivana Djuretic, PhD, Thomas Van Blarcom, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3921.
https://doi.org/10.1182/blood-2019-129025
Published: 2019
Journal Articles

ALLO-819, an Allogeneic Flt3 CAR T Therapy Possessing an Off-Switch for the Treatment of Acute Myeloid Leukemia

Cesar Sommer, PhD, Ivana Djuretic, PhD, Julien Valton, PhD, Duy Nguyen, Janette Sutton, Kris Poulsen, Julianne Smith, PhD, Ivana Djuretic, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3335.
https://doi.org/10.1182/blood-2018-99-117605
Published: 2018
Journal Articles

ALLO-715, an Allogeneic BCMA CAR T Therapy Possessing an Off-Switch for the Treatment of Multiple Myeloma

Cesar Sommer, PhD, Bijan Boldajipour, PhD, Julien Valton, PhD, Roman Galetto, PhD, Trevor Bentley, Janette Sutton, Yajin Ni, PhD, Mark Leonard, PhD, Thomas Van Blarcom, PhD, Julianne Smith, PhD, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 591.
https://doi.org/10.1182/blood-2018-99-119227
Published: 2018